Cargando…
Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
Helicobacter pylori colonizes the human stomach of half of the world’s population. The infection if not treated, persists through life, leading to chronic gastric inflammation, that may progress to severe diseases as peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphom...
Autores principales: | Sampaio, Pedro Sousa, Calado, Cecília R. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763841/ https://www.ncbi.nlm.nih.gov/pubmed/33322665 http://dx.doi.org/10.3390/antibiotics9120897 |
Ejemplares similares
-
Antigenic and conserved peptides from diverse Helicobacter pylori antigens
por: Calado, Cecília R. C.
Publicado: (2022) -
Plasma versus Serum Analysis by FTIR Spectroscopy to Capture the Human Physiological State
por: Araújo, Rúben, et al.
Publicado: (2022) -
Metabolic Fingerprinting with Fourier-Transform Infrared (FTIR) Spectroscopy: Towards a High-Throughput Screening Assay for Antibiotic Discovery and Mechanism-of-Action Elucidation
por: Ribeiro da Cunha, Bernardo, et al.
Publicado: (2020) -
The Impact of the
Serum Extraction Protocol on Metabolomic
Profiling Using UPLC-MS/MS and FTIR Spectroscopy
por: Fonseca, Tiago A. H., et al.
Publicado: (2023) -
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against Helicobacter pylori
por: Mohamed, Abdolhakim, et al.
Publicado: (2022)